美国针灸保险覆盖范围的范围综述
该范围综述采用Arksey与O'Malley框架,评估美国针灸保险覆盖的现有文献并识别知识空白。研究发现44个州缺乏已发表的针灸覆盖数据,尤其在中西部和南部;有数据地区大部分针灸使用者无保险覆盖。持照针灸师报销可能性及报销费率低于医师,实施覆盖的障碍包括提供者缺乏、非药物疗法时机判断困难及疗效与成本效果证据不足。
要点
- 美国44个州缺乏针灸保险覆盖的已发表数据,中西部和南部尤为明显。
- 有数据地区大部分针灸使用者无保险覆盖,持照针灸师报销率低于医师。
- 实施覆盖的障碍包括提供者缺乏、非药物疗法时机判断困难及证据不足。
核心结论
- 美国缺乏近期的针灸保险覆盖区域比较出版物和数据,商业保险计划数据不在公共领域是主要挑战。
研究设计与样本
- 采用Arksey与O'Malley框架的范围综述,遵循预先确定的研究方案进行一级摘要和二级全文筛选。
主要发现
- 44个州缺乏已发表的针灸覆盖数据,尤其在中西部和南部。
- 有数据地区大部分针灸使用者无保险覆盖。
- 持照针灸师较医师更少获得报销且报销费率更低。
- 实施覆盖的障碍包括提供者缺乏、非药物疗法时机判断困难及疗效与成本效果证据不足。
临床怎么用
- 临床可关注保险覆盖对针灸可及性的影响,并注意持照针灸师报销率低于医师的现实。
局限性
- 商业保险计划数据不在公共领域,且缺乏近期出版物比较美国各地区覆盖情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Increasing access to non-pharmacologic pain management modalities, including acupuncture, has the potential to reduce opioid overuse. A lack of insurance coverage for acupuncture could present a barrier for both patients and providers. The objective of this scoping review was to assess the existing literature on acupuncture insurance coverage in the United States and to identify knowledge gaps and research priorities. METHODS: We utilized the Arksey and O'Malley framework to guide our scoping review methodology. We followed a pre-determined study protocol for the level-one abstract and level-two full text screenings. We synthesized information into subject-area domains and identified knowledge gaps. RESULTS: We found a lack of published data on acupuncture coverage in 44 states, especially in the Midwest and the South. Where data were available, a large proportion of acupuncture users did not have insurance coverage. Consumer demand, state mandates, and efforts to reduce opioid use were motivations to cover acupuncture. Licensed acupuncturists were less likely to be reimbursed and were reimbursed at lower rates compared to physicians. Reported barriers encountered when implementing coverage included a lack of providers, challenges determining when to offer non-pharmacologic treatments, and a lack of evidence for clinical efficacy and cost-effectiveness. CONCLUSION: We found a lack of recent publications and data comparing regional coverage in the United States. A key challenge is that commercial insurance plan data are not in the public domain. Further research should assess insurance coverage implementation for acupuncture and measure the impact of policy changes on acupuncture utilization and rates of opioid overuse.
引用
- Bleck R, Marquez E, Gold MA, et al. A scoping review of acupuncture insurance coverage in the United States. Acupunct Med. 2020. PMID: 33307728. doi:10.1177/0964528420964214
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。